Vpriv® (velaglucerase alfa)
| Full Name | Vpriv® (velaglucerase alfa) |
| Drug | Vpriv |
| Manufacturer | Takeda Pharmaceuticals U.S.A., Inc. |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | Long-term enzyme replacement therapy (ERT) for pediatric and adult patients with type 1 Gaucher disease |
| Disease | Gaucher Type I Disease |
| Therapeutic Area | Neurology, Genetics |
| Enrollment Form Link | Vpriv Enrollment Form |
| Phone Number | 800-240-9572 |
| Fax Number | 877-220-7581 |
| Product Website | hcp.vpriv.com |